Table 3.
No. | Age, yr | Male | Female | Expression of PLC-δ2 | Follow-up (three years) | |||
---|---|---|---|---|---|---|---|---|
40–60 | 60–70 | 70–80 | ||||||
Healthy donors | 16 | 5 | 7 | 4 | 12 | 4 | Negative | – |
Type I IM | 17 | 9 | 6 | 2 | 12 | 5 | Negative | Type I IM (14), Gastric ulcer (3) |
Type I IM | 8 | 4 | 3 | 1 | 6 | 2 | Positive | Carcinoma* |
Type II IM | 10 | 3 | 4 | 3 | 8 | 2 | Positive | Carcinoma |
Carcinoma | 7 | 1 | 4 | 2 | 5 | 2 | Positive | – |
*P < 0.0001.
Site of biopsy: gastric antrum. The site was documented by monitored endoscopy.